{"schema_version":"secwatch.filing_event.v1","accession":"0001681622-23-000069","form_type":"8-K","ticker":"VREX","cik":"0001681622","company_name":"Varex Imaging Corp","filed_at":"2023-11-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.047325+00:00","generated_at":"2026-06-08T03:44:37.530358+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Varex Q4 FY2023 rev $227M; Medical down 10% YoY, Industrial up 27%; guides Q1 FY2024 rev $180-$200M","bullets":["Q4 revenue $227M, down 2% YoY and 2% sequentially; full-year record revenue $893M.","GAAP EPS $0.66 per diluted share; non-GAAP EPS $0.45 per diluted share.","Medical segment revenue down 10% YoY (China anti-corruption headwind); Industrial up 27% YoY.","Cash from operations $47M in Q4; cash & marketable securities $195M at year-end.","Q1 FY2024 guidance: revenue $180-$200M, non-GAAP EPS $0.00-$0.20."],"urls":{"canonical":"https://secwatch.observer/filing/0001681622-23-000069","json":"https://secwatch.observer/filing/0001681622-23-000069.json","markdown":"https://secwatch.observer/filing/0001681622-23-000069.md","text":"https://secwatch.observer/filing/0001681622-23-000069.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1681622/000168162223000069/0001681622-23-000069-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1681622/000168162223000069/vrex-20231114.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T03:44:37.530358+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4feca9b7d2a43eea9570e5a1ee7265e4db0b3ac2","claim":"Varex Imaging Corp reported for the twelve months ended September 29, 2023 (FY23) results: revenue $893 million, EPS $1.08 per diluted share (GAAP); $1.27 per diluted share (Non-GAAP).","evidence_excerpt":"FY23 Summary • Record revenues of $893 million • GAAP gross margin 32% | Non-GAAP gross margin* 33% • GAAP operating expense $213 million | Non-GAAP operating expense* $199 million • GAAP operating margin 9% | Non-GAAP operating margin* 11% • GAAP net income $1.08 per diluted share | Non-GAAP net income* $1.27 per diluted share • Cash flow from operations $108 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1681622/000168162223000069/0001681622-23-000069-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"for the twelve months ended September 29, 2023 (FY23)"},{"label":"Revenue","value":"$893 million"},{"label":"EPS","value":"$1.08 per diluted share (GAAP); $1.27 per diluted share (Non-GAAP)"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"7a5b4c903fdd45f8082a988593952cf26ccef533","claim":"Varex Imaging Corp reported for the first quarter of fiscal year 2024 results: revenue $180 million to $200 million, EPS $0.00 to $0.20 per diluted share (Non-GAAP). Guidance initiated.","evidence_excerpt":"Outlook The following guidance is provided for the first quarter of fiscal year 2024: • Revenues are expected to be between $180 million and $200 million • Non-GAAP net income per diluted share is expected to be between $0.00 and $0.20","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1681622/000168162223000069/0001681622-23-000069-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"for the first quarter of fiscal year 2024"},{"label":"Revenue","value":"$180 million to $200 million"},{"label":"EPS","value":"$0.00 to $0.20 per diluted share (Non-GAAP)"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"},{"claim_id":"bd1acda3e64e385ffdbd2503fe58744aae23cdb7","claim":"Varex Imaging Corp reported for the three months ended September 29, 2023 (Q4 FY23) results: revenue $227 million, EPS $0.66 per diluted share (GAAP); $0.45 per diluted share (Non-GAAP).","evidence_excerpt":"Q4 FY23 Summary • Revenues of $227 million • GAAP gross margin 34% | Non-GAAP gross margin* 36% • GAAP operating expense $54 million | Non-GAAP operating expense* $51 million • GAAP operating margin 11% | Non-GAAP operating margin* 13% • GAAP net income $0.66 per diluted share | Non-GAAP net income* $0.45 per diluted share • Cash flow from operations $47 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1681622/000168162223000069/0001681622-23-000069-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"for the three months ended September 29, 2023 (Q4 FY23)"},{"label":"Revenue","value":"$227 million"},{"label":"EPS","value":"$0.66 per diluted share (GAAP); $0.45 per diluted share (Non-GAAP)"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}